In German-speaking countries only about 10% of cases of gestational diabete
s (GDM) are diagnosed because screening is not widely performed. Undiagnose
d GDM leads to avoidable shortterm and long-term complications for the moth
er and the offspring. The mothers are at increased risk for hypertensive co
mplications of pregnancy, urinary tract infections, premature delivery and
caesarean delivery. The unrecognized predisposition to diabetes can be foll
owed by early manifestation of diabetes and diabetic sequelae later in life
. The fetus developes hyperinsulinism and is at risk for macrosomia and int
rauterine death. Newborns are at risk for prematurity and for characteristi
c diabetogenic fetopathy with hyperinsulinism, delayed adaptation, hypoglyc
emia, hypocalcemia, and hyperbilirubinemia. Malconditioning of the fetal is
let cell organ in utero predisposes the child and adolescent to obesity, im
paired glucose tolerance, and diabetes rater in life. Screening for GDM sho
uld lead to the detection and treatment of one otherwise undiagnosed case p
er 100 pregnancies. An undiagnosed case of GDM leads to costs of 106 693,-
Euro while screening 100 women would cost E 214,to E 3600,- at most. Thus,
a general screening policy for GDM would provide medical and economic benef
its.